Showing results (281-290 of 452) with videos related to

Sort By:
Pageof 46
Journal of Neurology|June 17, 2021
What happens after fingolimod discontinuation? A multicentre real-life experienceDoriana Landi, Alessio Signori, Maria Cellerino, et al.
Plos One|May 27, 2026
Vocational rehabilitation for people with multiple sclerosis: A systematic scoping review of international evidenceCarlotta Gualco, Erica Grange, Federica Rotondi, et al.
BMC Neurology|April 6, 2021
Possible progressive multifocal leukoencephalopathy and active multiple sclerosis under dimethyl fumarate: the central role of MRI in informing therapeutic decisionsElena Augusta Vola, Maria Petracca, Sirio Cocozza, et al.
Chronic Stress (Thousand Oaks, Calif.)|May 23, 2020
Initial Evidence for Brain Plasticity Following a Digital Therapeutic Intervention for DepressionMegan M Hoch, Gaelle E Doucet, Dominik A Moser, et al.
Therapeutic Advances in Neurological Disorders|March 5, 2026
Positioning siponimod and the post-treatment gap: the unmet needs of SPMS patients in Italian real-world practiceAurora Zanghì, Giovanna Borriello, Matteo Foschi, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 23, 2021
Predictors of Ocrelizumab Effectiveness in Patients with Multiple SclerosisMaria Cellerino, Giacomo Boffa, Caterina Lapucci, et al.
La Medicina Del Lavoro|June 26, 2024
Occupational Physicians' Management of Workers With Multiple Sclerosis in Italy: Results From a SurveyBruna Maria Rondinone, Giuliana Buresti, Sergio Iavicoli, et al.
Multiple Sclerosis and Related Disorders|January 17, 2025
Improvement of measured and perceived disability in overweight patients with Multiple Sclerosis trough different patterns of Mediterranean hypocaloric dietFederica Felicetti, Serena Ruggieri, Ilaria Ruotolo, et al.
International Neurourology Journal|May 6, 2021
Interplay Between Cognitive and Bowel/Bladder Function in Multiple SclerosisAntonio Carotenuto, Teresa Costabile, Marcello Moccia, et al.
Immunopharmacology and Immunotoxicology|August 8, 2008
Interleukin-10 and interleukin-12 modulation in patients with relapsing-remitting multiple sclerosis on therapy with interferon-beta 1a: differences in responders and non respondersPietro B Carrieri, Paolo Ladogana, Gaetano Di Spigna, et al.
Pageof 46